Medtronic launched a long-term global clinical study to collect prospective data on INFUSE® bone graft in posterolateral (PLF) and transforaminal lumbar interbody fusion (TLIF) procedures.
B.O.N.E (BMP Outcomes and New Evidence in PLF and TLIF Procedures) is a multi-center, 10-year program enrolling 550-700 patients at up to 50 sites between the Pilot and Pivotal studies of both procedures. The PLF pilot of ~125 patients will be followed by a TLIF Pilot study in 2018. If successful, pilot studies would be followed by the larger pivotal study.
Medtronic seeks to generate data to expand indications and provide additional options to treat spinal patients.
Source: Medtronic
Medtronic launched a long-term global clinical study to collect prospective data on INFUSE® bone graft in posterolateral (PLF) and transforaminal lumbar interbody fusion (TLIF) procedures.
B.O.N.E (BMP Outcomes and New Evidence in PLF and TLIF Procedures) is a multi-center, 10-year program enrolling 550-700 patients at up to 50 sites...
Medtronic launched a long-term global clinical study to collect prospective data on INFUSE® bone graft in posterolateral (PLF) and transforaminal lumbar interbody fusion (TLIF) procedures.
B.O.N.E (BMP Outcomes and New Evidence in PLF and TLIF Procedures) is a multi-center, 10-year program enrolling 550-700 patients at up to 50 sites between the Pilot and Pivotal studies of both procedures. The PLF pilot of ~125 patients will be followed by a TLIF Pilot study in 2018. If successful, pilot studies would be followed by the larger pivotal study.
Medtronic seeks to generate data to expand indications and provide additional options to treat spinal patients.
Source: Medtronic
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more
Copy to clipboard 
